Valiant Laboratories Limited (NSE:VALIANTLAB)

Valiant Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-22.01	3.2	289.98	340.74
Depreciation & Amortization	20.93	19.66	15.63	24.26
Loss (Gain) From Sale of Assets	-0.05	-	-	-0.59
Provision & Write-off of Bad Debts	8.48	-	-	-
Other Operating Activities	45.07	-0.3	3.31	-10.28
Change in Accounts Receivable	-272.42	428.41	222.01	-791.1
Change in Inventory	60.27	30.27	27.62	21.15
Change in Accounts Payable	147.89	-213.69	80.24	480.6
Change in Other Net Operating Assets	24.99	-248.69	-78.28	72.9
Operating Cash Flow	13.13	18.85	560.51	137.68
Operating Cash Flow Growth	-30.34%	-96.64%	307.12%	-
Capital Expenditures	-1,139	-458.7	-376.81	-88.2
Sale of Property, Plant & Equipment	0.56	-	-	0.59
Investment in Securities	610.3	-980.07	-136.97	-
Other Investing Activities	-	-	-37.91	-143.25
Investing Cash Flow	-527.68	-1,439	-551.68	-230.85
Short-Term Debt Issued	154.68	13.88	-	-
Long-Term Debt Issued	296.86	152.63	3.72	-
Total Debt Issued	451.54	166.5	3.72	19.21
Short-Term Debt Repaid	-	-	-12.81	-
Total Debt Repaid	-	-	-12.81	-440.25
Net Debt Issued (Repaid)	451.54	166.5	-9.09	-421.04
Issuance of Common Stock	-	1,359	-	733.49
Other Financing Activities	-5.01	-0.78	-0.25	-0.88
Financing Cash Flow	446.53	1,524	-9.34	311.57
Miscellaneous Cash Flow Adjustments	-0	-	-	0
Net Cash Flow	-68.02	104.57	-0.51	218.39
Free Cash Flow	-1,125	-439.85	183.7	49.48
Free Cash Flow Growth	-	-	271.26%	-
Free Cash Flow Margin	-84.37%	-24.16%	5.50%	1.58%
Free Cash Flow Per Share	-26.07	-11.57	5.64	1.52
Cash Interest Paid	1.75	0.78	0.25	0.36
Cash Income Tax Paid	-24.65	-9.82	88	115.88
Levered Free Cash Flow	-1,359	-400.31	290.4	-
Unlevered Free Cash Flow	-1,358	-399.83	291.98	-
Change in Net Working Capital	198.35	-104.05	-443.62	-

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.